PMI
Price
$7.39
Change
-$2.24 (-23.26%)
Updated
Oct 22, 04:59 PM (EDT)
Capitalization
22.52M
22 days until earnings call
Intraday BUY SELL Signals
XTNT
Price
$0.31
Change
+$0.01 (+3.33%)
Updated
Oct 22, 04:59 PM (EDT)
Capitalization
41.53M
18 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

PMI vs XTNT

PMI vs XTNT Comparison Chart in %
loading
loading
View a ticker or compare two or three
VS
PMI vs. XTNT commentary
Oct 22, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is PMI is a Hold and XTNT is a Buy.

Interact to see
Advertisement
SUMMARIES
A.I.Advisor
a Summary for PMI with price predictions
Oct 21, 2026

PMI's RSI Oscillator leaves overbought zone

The 10-day RSI Oscillator for PMI moved out of overbought territory on October 20, 2026. This could be a sign that the stock is shifting from an upward trend to a downward trend. Traders may want to look at selling the stock or buying put options. Tickeron's A.I.dvisor looked at 3 instances where the indicator moved out of the overbought zone. In 3 of the 3 cases the stock moved lower in the days that followed. This puts the odds of a move down at 90%.

Price Prediction Chart

Technical Analysis (Indicators)

Bearish Trend Analysis

The Stochastic Oscillator may be shifting from an upward trend to a downward trend. In 4 of 4 cases where PMI's Stochastic Oscillator exited the overbought zone, the price fell further within the following month. The odds of a continued downward trend are 90%.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where PMI declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 90%.

PMI broke above its upper Bollinger Band on October 13, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

Bullish Trend Analysis

The Momentum Indicator moved above the 0 level on October 02, 2026. You may want to consider a long position or call options on PMI as a result. In 8 of 12 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 67%.

The Moving Average Convergence Divergence (MACD) for PMI just turned positive on October 02, 2026. Looking at past instances where PMI's MACD turned positive, the stock continued to rise in 5 of 6 cases over the following month. The odds of a continued upward trend are 83%.

PMI moved above its 50-day moving average on October 02, 2026 date and that indicates a change from a downward trend to an upward trend.

The 10-day moving average for PMI crossed bullishly above the 50-day moving average on October 06, 2026. This indicates that the trend has shifted higher and could be considered a buy signal. In 1 of 1 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are 90%.

Following a +54.50% 3-day Advance, the price is estimated to grow further. Considering data from situations where PMI advanced for three days, in 32 of 39 cases, the price rose further within the following month. The odds of a continued upward trend are 82%.

The Aroon Indicator entered an Uptrend today. In 10 of 12 cases where PMI Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are 83%.

Fundamental Analysis (Ratings)

The Tickeron Price Growth Rating for this company is 34 (best 1 - 100 worst), indicating steady price growth. PMI’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Valuation Rating of 58 (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (13.124) is normal, around the industry mean (2.923). P/E Ratio (-0.269) is within average values for comparable stocks, (2.388). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (11.052). Dividend Yield (0.000) settles around the average of (0.009) among similar stocks. P/S Ratio (2.114) is also within normal values, averaging (40.124).

The Tickeron PE Growth Rating for this company is 100 (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron SMR rating for this company is 100 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. PMI’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 95, placing this stock worse than average.

A.I.Advisor
a Summary for XTNT with price predictions
Oct 21, 2026

XTNT's RSI Indicator ascending out of oversold territory

The RSI Indicator for XTNT moved out of oversold territory on October 20, 2026. This could be a sign that the stock is shifting from a downward trend to an upward trend. Traders may want to buy the stock or call options. The A.I.dvisor looked at 30 similar instances when the indicator left oversold territory. In 29 of the 30 cases the stock moved higher. This puts the odds of a move higher at 90%.

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Stochastic Oscillator suggests the stock price trend may be in a reversal from a downward trend to an upward trend. 42 of 48 cases where XTNT's Stochastic Oscillator exited the oversold zone resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 88%.

Following a +5.68% 3-day Advance, the price is estimated to grow further. Considering data from situations where XTNT advanced for three days, in 194 of 230 cases, the price rose further within the following month. The odds of a continued upward trend are 84%.

XTNT may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

Bearish Trend Analysis

The Momentum Indicator moved below the 0 level on October 05, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on XTNT as a result. In 81 of 91 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 89%.

The Moving Average Convergence Divergence Histogram (MACD) for XTNT turned negative on October 05, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 47 similar instances when the indicator turned negative. In 43 of the 47 cases the stock turned lower in the days that followed. This puts the odds of success at 90%.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where XTNT declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 83%.

Fundamental Analysis (Ratings)

The Tickeron Valuation Rating of 28 (best 1 - 100 worst) indicates that the company is slightly undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (1.038) is normal, around the industry mean (2.923). P/E Ratio (-3.700) is within average values for comparable stocks, (2.388). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (11.052). Dividend Yield (0.000) settles around the average of (0.009) among similar stocks. P/S Ratio (0.426) is also within normal values, averaging (40.124).

The Tickeron Price Growth Rating for this company is 81 (best 1 - 100 worst), indicating slightly worse than average price growth. XTNT’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron SMR rating for this company is 96 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron PE Growth Rating for this company is 97 (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. XTNT’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 95, placing this stock worse than average.

FUNDAMENTALS RATINGS
XTNT: Fundamental Ratings
XTNT
OUTLOOK RATING
1..100
67
VALUATION
overvalued / fair valued / undervalued
1..100
28
Undervalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
96
PRICE GROWTH RATING
1..100
81
P/E GROWTH RATING
1..100
97
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
PMIXTNT
RSI
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
90%
Stochastic
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
88%
Momentum
ODDS (%)
Bullish Trend 2 days ago
67%
Bearish Trend 2 days ago
89%
MACD
ODDS (%)
Bullish Trend 2 days ago
83%
Bearish Trend 2 days ago
90%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
86%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
88%
Bearish Trend 2 days ago
87%
Advances
ODDS (%)
Bullish Trend 4 days ago
82%
Bullish Trend 3 days ago
84%
Declines
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 7 days ago
83%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
90%
Aroon
ODDS (%)
Bullish Trend 2 days ago
83%
N/A
COMPARISON
Comparison
Oct 22, 2026
Stock price -- (PMI: $9.63 vs. XTNT: $0.30)
Brand notoriety: PMI and XTNT are both not notable
Both companies represent the Medical/Nursing Services industry
Current volume relative to the 65-day Moving Average: PMI: 19% vs. XTNT: 6%
Market capitalization -- PMI: $22.52M vs. XTNT: $41.53M
PMI [@Medical/Nursing Services] is valued at $22.52M. XTNT’s [@Medical/Nursing Services] market capitalization is $41.53M. The market cap for tickers in the [@Medical/Nursing Services] industry ranges from $837 to $173.92B. The average market capitalization across the [@Medical/Nursing Services] industry is $5.76B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is overvalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

PMI’s FA Score shows that 0 FA rating(s) are green while XTNT’s FA Score has 1 green FA rating(s).

  • PMI’s FA Score: 0 green, 5 red.
  • XTNT’s FA Score: 1 green, 4 red.
According to our system of comparison, PMI is a better buy in the long-term than XTNT.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

PMI’s TA Score shows that 6 TA indicator(s) are bullish while XTNT’s TA Score has 4 bullish TA indicator(s).

  • PMI’s TA Score: 6 bullish, 4 bearish.
  • XTNT’s TA Score: 4 bullish, 3 bearish.
According to our system of comparison, PMI is a better buy in the short-term than XTNT.

Price Growth

PMI (@Medical/Nursing Services) experienced а -24.05% price change this week, while XTNT (@Medical/Nursing Services) price change was -7.06% for the same time period.

The average weekly price growth across all stocks in the @Medical/Nursing Services industry was -1.59%. For the same industry, the average monthly price growth was -10.79%, and the average quarterly price growth was -10.52%.

Reported Earning Dates

PMI is expected to report earnings on Nov 13, 2026.

XTNT is expected to report earnings on Nov 09, 2026.

Industries' Descriptions

@Medical/Nursing Services (-1.59% weekly)

The medical/nursing services includes companies that provide medical-related services such as ambulance services, dialysis centers, respiratory therapy, blood testing and rehabilitation services. DaVita Inc., Chemed Corporation and Guardant Health, Inc. are examples of companies in this industry.

View a ticker or compare two or three
PMI
Daily Signal:
Gain/Loss:
XTNT
Daily Signal:
Gain/Loss:
Interact to see
Advertisement

PMI and

Correlation & Price change

A.I.dvisor tells us that PMI and AVR have been poorly correlated (+19% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that PMI and AVR's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To PMI
1D Price
Change %
PMI100%
-8.11%
AVR - PMI
19%
Poorly correlated
-4.45%
BFLY - PMI
10%
Poorly correlated
-2.87%
CBLL - PMI
8%
Poorly correlated
-1.95%
RXST - PMI
6%
Poorly correlated
+0.41%
XTNT - PMI
6%
Poorly correlated
-2.31%
More

XTNT and

Correlation & Price change

A.I.dvisor tells us that XTNT and STRRP have been poorly correlated (+31% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that XTNT and STRRP's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To XTNT
1D Price
Change %
XTNT100%
-2.31%
STRRP - XTNT
31%
Poorly correlated
-2.43%
CVRX - XTNT
26%
Poorly correlated
-1.44%
ACRS - XTNT
25%
Poorly correlated
+1.06%
MBOT - XTNT
24%
Poorly correlated
-0.78%
OM - XTNT
24%
Poorly correlated
-4.03%
More
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
SHEL105.36-0.18
-0.17%
Shell plc
ACET4.49-0.03
-0.66%
Adicet Bio Inc
MGPI14.88-0.25
-1.65%
MGP Ingredients
PRAX256.47-8.02
-3.03%
Praxis Precision Medicines
GPCR22.01-0.87
-3.80%
Structure Therapeutics